IDEX Biometrics ASA (OSL:IDEX)
Norway · Delayed Price · Currency is NOK 2.800
-0.170 (-5.72%)
Oct 3, 2025, 4:25 PM CET
IDEX Biometrics ASA Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 0.27 | 0.84 | 4.14 | 4.09 | 2.84 | 1.1 | Upgrade |
| 0.27 | 0.84 | 4.14 | 4.09 | 2.84 | 1.1 | Upgrade | |
Revenue Growth (YoY) | -87.73% | -79.68% | 1.15% | 44.09% | 159.36% | 158.25% | Upgrade |
Cost of Revenue | 1.36 | 1.68 | 3.91 | 3.24 | 1.25 | 0.28 | Upgrade |
Gross Profit | -1.09 | -0.84 | 0.23 | 0.85 | 1.59 | 0.82 | Upgrade |
Selling, General & Admin | 4.69 | 8.8 | 14.31 | 19.21 | 21.11 | 17.67 | Upgrade |
Research & Development | 2.31 | 2.46 | 2.39 | 3.25 | 2.68 | 1.9 | Upgrade |
Other Operating Expenses | 6.73 | 7.29 | 8.74 | 8.4 | 7.35 | 5.94 | Upgrade |
Operating Expenses | 15.04 | 21.06 | 27.08 | 32.22 | 32.94 | 27.22 | Upgrade |
Operating Income | -16.12 | -21.9 | -26.85 | -31.37 | -31.35 | -26.4 | Upgrade |
Interest Expense | -1.77 | -2.41 | -0.64 | -0.03 | -0.03 | -0.06 | Upgrade |
Interest & Investment Income | 7.84 | 7.91 | 0.84 | 0.1 | 0.01 | 0.03 | Upgrade |
Currency Exchange Gain (Loss) | -0.2 | - | - | -1.39 | -1.09 | -0.41 | Upgrade |
Other Non Operating Income (Expenses) | 3.64 | -0 | -0 | -0 | - | - | Upgrade |
EBT Excluding Unusual Items | -6.61 | -16.41 | -26.65 | -32.7 | -32.46 | -26.85 | Upgrade |
Other Unusual Items | -2.13 | 1.84 | - | - | - | - | Upgrade |
Pretax Income | -8.74 | -14.57 | -26.65 | -32.7 | -32.46 | -26.85 | Upgrade |
Income Tax Expense | -0.16 | -0.12 | -0.02 | -0.04 | 0.09 | -0.1 | Upgrade |
Net Income | -8.57 | -14.45 | -26.63 | -32.66 | -32.55 | -26.75 | Upgrade |
Net Income to Common | -8.57 | -14.45 | -26.63 | -32.66 | -32.55 | -26.75 | Upgrade |
Shares Outstanding (Basic) | 12 | 4 | 3 | 2 | 2 | 2 | Upgrade |
Shares Outstanding (Diluted) | 12 | 4 | 3 | 2 | 2 | 2 | Upgrade |
Shares Change (YoY) | 345.58% | 64.15% | 23.20% | 11.76% | 19.79% | 28.19% | Upgrade |
EPS (Basic) | -0.70 | -3.48 | -10.52 | -15.90 | -17.71 | -17.44 | Upgrade |
EPS (Diluted) | -0.70 | -3.48 | -10.52 | -16.00 | -17.71 | -17.44 | Upgrade |
Free Cash Flow | -9.83 | -17.53 | -27.25 | -31.64 | -27.67 | -23.45 | Upgrade |
Free Cash Flow Per Share | -0.80 | -4.22 | -10.77 | -15.40 | -15.06 | -15.28 | Upgrade |
Gross Margin | - | -100.24% | 5.58% | 20.72% | 55.84% | 74.89% | Upgrade |
Operating Margin | -5994.05% | -2604.40% | -648.59% | -766.59% | -1103.87% | -2411.14% | Upgrade |
Profit Margin | -3187.36% | -1718.07% | -643.37% | -798.19% | -1146.20% | -2443.29% | Upgrade |
Free Cash Flow Margin | -3655.76% | -2084.90% | -658.32% | -773.14% | -974.44% | -2141.19% | Upgrade |
EBITDA | -15.45 | -20.88 | -25.82 | -30.45 | -30.37 | -25.49 | Upgrade |
D&A For EBITDA | 0.67 | 1.03 | 1.03 | 0.92 | 0.98 | 0.91 | Upgrade |
EBIT | -16.12 | -21.9 | -26.85 | -31.37 | -31.35 | -26.4 | Upgrade |
Revenue as Reported | 0.27 | 0.84 | 4.14 | 4.09 | 2.84 | 1.1 | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.